- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07006948
Cutting-Edge Study on Machine-Assisted Autism Screening in Young Children
This important multicenter study will evaluate a machine-assisted system for early screening of autism spectrum disorder (ASD) in toddlers aged 1.5 to 2.5 years. The research team will assess how accurately this technology can identify ASD compared to standard diagnostic methods. The study will involve 1,000 children across four groups: those with ASD, global developmental delay (GDD), language disorder (LD), and typically developing (TD) children.
Early detection of autism is crucial because:
- Early intervention leads to better long-term outcomes
- Children can get support during critical developmental windows
- Families can access appropriate resources sooner
- It reduces the "diagnostic odyssey" many families experience
The study uses two well-established diagnostic tools as benchmarks: the Autism Diagnostic Observation Schedule (ADOS-2) and the Griffiths Developmental Scales-Chinese edition (GDS-C). These will help researchers determine if the machine-assisted system works as effectively as current gold-standard methods.
For families considering participation, here's what you should know:
- The study involves children between 18-30 months old
- Participation includes standard developmental assessments
- Children from all developmental backgrounds are needed
- The research may contribute to better screening tools for future generations
The exclusion criteria help ensure safety and proper grouping. Children with certain genetic conditions, neurological disorders, or significant medical histories won't be included. This helps researchers get clear results about how well the screening system works specifically for autism-related concerns.
This research is particularly significant because:
- Current wait times for autism evaluations can be months or years
- Many communities lack specialists trained in autism diagnosis
- Objective screening tools could reduce disparities in access to care
- Early screening could benefit children with various developmental differences
The study will run from June 2025 to June 2028 across multiple hospitals in China, led by the Children's Hospital of Fudan University. The collaboration between so many institutions means the results will reflect diverse populations, making any findings more broadly applicable.
For parents and caregivers, understanding these research efforts is valuable because:
- It shows the scientific community's commitment to improving early detection
- It demonstrates how technology might help solve current diagnostic challenges
- It highlights the importance of developmental monitoring in toddlerhood
- It may lead to more accessible screening options in pediatric settings
The study measures several important outcomes, including social behaviors like responding to names, following instructions, and joint attention. These are fundamental skills that parents often notice first when concerned about development. By comparing human observations with machine assessments, researchers hope to create tools that can reliably flag early signs of autism.
This research represents an exciting intersection of clinical expertise and technological innovation. While nothing replaces comprehensive evaluation by specialists, reliable screening tools could help identify children who need full assessments sooner. For families navigating developmental concerns, studies like this offer hope for more accessible, timely support in the future.
Upcoming Clinical Trials
-
NCT07803653Not yet recruitingStage IVB Prostate Cancer AJCC v8 | Metastatic Castration-Resistant Prostate Adenocarcinoma
-
NCT07803666Not yet recruitingExercise | Blood Pressure | Nutrition Knowledge
-
NCT07803692Not yet recruiting
-
NCT07803705Not yet recruitingObesity | Overweight | Fatty Pancreas
-
NCT07803718Not yet recruitingPeripheral Artery Disease | Atherectomy in Diseased Lower Extremity Arteries
-
NCT07803731Not yet recruitingSacroiliac Joint Dysfunction
-
NCT07803744Not yet recruitingObesity | Diabetes Mellitus, Type 1 | Overweight
-
NCT07803757Not yet recruitingDental Caries | Cervical Caries
-
NCT07803770Not yet recruitingPancreatic Neoplasms | Radiomics | Pancreatic Ductal Adenocarcinoma (PDAC) | Endoscopic Ultrasound (EUS) | Artificial Intelligence (AI)
-
NCT07803783Not yet recruitingMetastatic Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma (PDAC)
-
NCT07803796Not yet recruitingBody Dysmorhpic Disorder | Positive Psychology
-
NCT07803809RecruitingType 2 Diabetes Mellitus (T2DM) | MASH - Metabolic Dysfunction-Associated Steatohepatitis | Overweight , Obesity